FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/05/013786 [Registered on: 09/05/2018] Trial Registered Prospectively
Last Modified On: 09/05/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of anal administration of an ayurvedic preparation "Panchtiktaguggulu Ghrita" in Osteoarthritis.  
Scientific Title of Study   Study to evaluate the efficacy of Matra Vasti of Panchtiktaguggulu Ghrita in Sandhivata(Osteoarthritis) 
Trial Acronym  Sandhigata vata 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrNRSingh 
Designation  Prof.& HOD  
Affiliation  Ch.Brahm Prakash Ayurved Charak Sansthan,New Delhi 
Address  PG dept. of kaya chikitsa, Ch.Brahm Prakash Ayurved Charak Sansthan,Khera Dabar, Najafgarh, New Delhi 73.
Ch.Brahm Prakash Ayurved Charak Sansthan,Khera Dabar, Najafgarh, New Delhi 73.
New Delhi
DELHI
110073
India 
Phone  9560659728  
Fax    
Email  naimishraj@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  DrNRSingh 
Designation  Prof.& HOD  
Affiliation  Ch.Brahm Prakash Ayurved Charak Sansthan,New Delhi 
Address  PG dept. of kaya chikitsa, Ch.Brahm Prakash Ayurved Charak Sansthan,Khera Dabar, Najafgarh, New Delhi 73.
Ch.Brahm Prakash Ayurved Charak Sansthan,Khera Dabar, Najafgarh, New Delhi 73.
New Delhi
DELHI
110073
India 
Phone  9560659728  
Fax    
Email  naimishraj@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DrNeetu Sharma 
Designation  P.G.Scholar 
Affiliation  Ch.Brahm Prakash Ayurved Charak Sansthan,New Delhi 
Address  PG dept. of kaya chikitsa, Ch.Brahm Prakash Ayurved Charak Sansthan,Khera Dabar, Najafgarh, New Delhi 73.
Ch.Brahm Prakash Ayurved Charak Sansthan,Khera Dabar, Najafgarh, New Delhi 73.
New Delhi
DELHI
110073
India 
Phone  7615050724  
Fax    
Email  drneetu90@gmail.com  
 
Source of Monetary or Material Support  
Ch.Brahm Prakash Ayurved Charak Sansthan, Khera Dabar, New Delhi-73 
 
Primary Sponsor  
Name  ChBrahm Prakash Ayurved Charak Sansthan 
Address  Ch.Brahm Prakash Ayurved Charak Sansthan,New Delhi 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr NRSingh  Ch.Brahm Prakash Ayurved Charak Sansthan,Khera Dabar,Najafgarh,New Delhi 73  Room No. 146 Dept. of Kayachikitsa , Academic Block
New Delhi
DELHI 
9560659728

naimishraj@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Ch.Brahm Prakash Ayurved Charak Sansthan  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients suffering from Osteoarthritis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Laksha guggulu  Patients will be randomly divided in 2 groups of 20 patients in each.. Group A-Laksha guggulu 2 tab TDS orally, Group B-Laksha guggulu 2 tab TDS orally with 50 ml matra vasti of Panchtiktaguggulu Ghrita.  
Intervention  Panchtiktaguggulu ghrita   In group B-50 ml matra vasti of panchtikta guggulu ghrita per day with Laksha guggulu 2 tab TDS . 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients having the symptoms of osteoarthritis(OA)and having Radiological evidence of OA 
 
ExclusionCriteria 
Details  Age below 40 yrs and above 70 yrs.Patients having Hypertension,Tuberculosis,Diabetes mellitus,Carcinoma,Cardiac disorder,Rheumatoid arthritis. Patients with ligamental injury of knee joint. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Symptoms of osteoarthritis and
Radiological evidence 
16 days with follow ups for 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Swelling of the knee joint,Distance walked by pt.,Movement of knee joint,Pain in joint  16 days with follow ups for 3 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/05/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not Applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   I will select patients ramdomly having symptoms and radiological evidence of Osteoarthritis.Patients will devided into 2 groups (A & B).Drug will be provided to group A -Laksha guggulu 2 tab TDS orally for 16 days and in other group B Laksha guggulu 2 tab TDS orally with Matra vasti of Panchtikta guggulu Ghrita 50 ml per day for 16 days. Screening will be done on first day .Here is plan of study ..

PLAN OF STUDY

INTERVENTIONS

DAY 0

DAY 1

DAY 2 TO 17

DAY 18

DAY 49

Screening

ü

 

 

 

 

Physical examination

 

ü

 

ü

ü

Assessment of  Pain

 

ü

 

ü

ü

Movements

 

ü

 

ü

ü

Distance walked by Pt. in 15 minutes

 

ü

 

ü

ü

Swelling

 

ü

 

ü

ü

ESR

 

ü

 

ü

ü

X-Ray of knee joint

 

ü

 

 

ü

Group Allocation

 

ü

 

 

 

Continuation of  Treatment

 

 

ü

 

 

 Then weekly follow ups will be for 3 months after completion of treatment.


 
Close